Universal Beteiligungs und Servicegesellschaft mbH Lowers Holdings in The Clorox Company $CLX

Universal Beteiligungs und Servicegesellschaft mbH lowered its position in The Clorox Company (NYSE:CLX) by 3.3% during the 2nd quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The institutional investor owned 128,924 shares of the company’s stock after selling 4,337 shares during the quarter. Universal Beteiligungs und Servicegesellschaft mbH owned approximately 0.10% of Clorox worth $15,480,000 as of its most recent SEC filing.

A number of other institutional investors and hedge funds have also bought and sold shares of CLX. American National Bank & Trust grew its position in shares of Clorox by 69.5% during the 2nd quarter. American National Bank & Trust now owns 217 shares of the company’s stock worth $26,000 after buying an additional 89 shares in the last quarter. NewSquare Capital LLC lifted its stake in Clorox by 567.6% in the second quarter. NewSquare Capital LLC now owns 227 shares of the company’s stock worth $27,000 after acquiring an additional 193 shares during the period. Ransom Advisory Ltd bought a new position in Clorox during the 1st quarter worth about $35,000. Hantz Financial Services Inc. purchased a new position in Clorox during the 2nd quarter valued at about $31,000. Finally, GW&K Investment Management LLC raised its holdings in shares of Clorox by 239.1% in the 1st quarter. GW&K Investment Management LLC now owns 295 shares of the company’s stock valued at $43,000 after purchasing an additional 208 shares in the last quarter. 78.53% of the stock is owned by institutional investors.

Clorox Price Performance

Shares of NYSE CLX opened at $100.10 on Wednesday. The Clorox Company has a fifty-two week low of $99.63 and a fifty-two week high of $171.37. The company has a market cap of $12.21 billion, a PE ratio of 15.35, a P/E/G ratio of 0.92 and a beta of 0.52. The company has a debt-to-equity ratio of 5.15, a quick ratio of 0.57 and a current ratio of 0.84. The business has a 50-day simple moving average of $116.67 and a two-hundred day simple moving average of $122.95.

Clorox (NYSE:CLX) last announced its quarterly earnings data on Monday, November 3rd. The company reported $0.85 EPS for the quarter, beating the consensus estimate of $0.78 by $0.07. The firm had revenue of $1.43 billion during the quarter, compared to analyst estimates of $1.41 billion. Clorox had a net margin of 11.40% and a return on equity of 377.86%. Clorox’s revenue was down 18.9% on a year-over-year basis. During the same period last year, the firm posted $1.86 EPS. Clorox has set its FY 2026 guidance at 5.950-6.300 EPS. As a group, equities analysts expect that The Clorox Company will post 7.15 EPS for the current fiscal year.

Clorox Dividend Announcement

The company also recently announced a quarterly dividend, which will be paid on Friday, February 13th. Investors of record on Wednesday, January 28th will be paid a $1.24 dividend. The ex-dividend date is Wednesday, January 28th. This represents a $4.96 dividend on an annualized basis and a yield of 5.0%. Clorox’s dividend payout ratio (DPR) is 77.86%.

Insider Buying and Selling

In other Clorox news, COO Eric H. Reynolds sold 15,041 shares of the business’s stock in a transaction dated Thursday, September 4th. The stock was sold at an average price of $123.78, for a total transaction of $1,861,774.98. Following the sale, the chief operating officer owned 54,221 shares in the company, valued at approximately $6,711,475.38. The trade was a 21.72% decrease in their position. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through the SEC website. Corporate insiders own 0.63% of the company’s stock.

Analysts Set New Price Targets

CLX has been the topic of a number of recent research reports. BNP Paribas Exane dropped their price objective on shares of Clorox from $110.00 to $103.00 and set an “underperform” rating on the stock in a research note on Tuesday, November 4th. Morgan Stanley lowered their target price on Clorox from $137.00 to $125.00 and set an “equal weight” rating for the company in a report on Tuesday, November 4th. Barclays cut their price target on Clorox from $112.00 to $108.00 and set an “underweight” rating on the stock in a report on Tuesday, November 4th. TD Cowen decreased their price objective on Clorox from $120.00 to $117.00 and set a “hold” rating for the company in a research note on Wednesday, October 1st. Finally, Bank of America dropped their price objective on Clorox from $135.00 to $125.00 and set a “neutral” rating on the stock in a research report on Wednesday, October 8th. One analyst has rated the stock with a Buy rating, twelve have given a Hold rating and five have assigned a Sell rating to the company. According to data from MarketBeat.com, Clorox presently has a consensus rating of “Reduce” and an average target price of $125.69.

Clorox Company Profile

The Clorox Company manufactures and markets consumer and professional products worldwide. It operates through four segments: Health and Wellness, Household, Lifestyle, and International. The Health and Wellness segment offers cleaning products, such as laundry additives and home care products primarily under the Clorox, Clorox2, Scentiva, Pine-Sol, Liquid-Plumr, Tilex, and Formula 409 brands; professional cleaning and disinfecting products under the CloroxPro and Clorox Healthcare brands; professional food service products under the Hidden Valley brand; and vitamins, minerals and supplement products under the RenewLife, Natural Vitality, NeoCell, and Rainbow Light brands in the United States.